ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. Show more
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.78 | -13.3533383346 | 13.33 | 13.6 | 11.55 | 1171652 | 12.34913247 | CS |
4 | -2.15 | -15.6934306569 | 13.7 | 14.9 | 11.55 | 976036 | 13.39675575 | CS |
12 | -2.54 | -18.0269694819 | 14.09 | 18.51 | 11.55 | 1048341 | 14.63898735 | CS |
26 | 2.98 | 34.772462077 | 8.57 | 18.51 | 7.55 | 1045419 | 13.25552201 | CS |
52 | 6.32 | 120.841300191 | 5.23 | 18.51 | 5.02 | 791308 | 11.64656989 | CS |
156 | 6.27 | 118.75 | 5.28 | 18.51 | 2.55 | 823041 | 8.63537234 | CS |
260 | 6.27 | 118.75 | 5.28 | 18.51 | 2.55 | 823041 | 8.63537234 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.